| Description |
1 online resource |
| Series |
Psychiatry- theory, applications, and treatments |
|
Psychiatry- theory, applications, and treatments series.
|
| Contents |
ANTIPSYCHOTIC DRUGS: PHARMACOLOGY, SIDE EFFECTS AND ABUSE PREVENTION; ANTIPSYCHOTIC DRUGS: PHARMACOLOGY, SIDE EFFECTS AND ABUSE PREVENTION; Library of Congress Cataloging-in-Publication Data; Contents; Acknowledgment; Part I: History; Chapter 1: Antipsychotics: Where Have We Been? Where Are We Now?Where Are We Going?; Where Have We Been?; Where Are We Now; Where Are We Going; References; Chapter 2: Second Generation Antipsychotic Medications in the Treatment of Affective Disorders; Abstract; Introduction; Treatment-Resistant Depression; Fundamentals; Augmentation and Combination |
|
Documentation during the Managementof Combination Strategies; Atypical Antipsychotic Medications As Augmentation; Amisulpiride; Aripiprazole; Asenapine; Clozapine; Olanzapine; Quetiapine; Risperidone; Sulpiride; Ziprazidone; Conclusion; Appendix 1. Second Generation Antipsychotics; Appendix 2. Acute Mania; Appendix 3. Bipolar Depression; Appendix 4. SGAs in MDD; References; Chapter 3: Antipsychotic Drugs and Children: The Good, the Bad, and What to Do About It; Abstract; Introduction; The Good; The Bad; What to Do About It; Conclusion; References |
|
Part II: Pharmocokinetics / Pharmacodynamics / ApplicationsChapter 4: Pharmacokinetic Properties of Second Generation Antipsychotics; Abstract; Introduction; Aripiprazole; Olanzapine; Loperidone; Asenapine; Paliperidone; Risperidone; Lurasidone; Ziprasidone; Quetiapine; Conclusion; References; Chapter 5: Translating Basic Science into Clinical Practice While Dosing the Second Generation Antipsychotics; Abstract; Introduction; Second Generation Antipsychotic Dosing; Specific Dosing Strategies; Common Features; Risperidone; Paliperidone; Olanzapine; Quetiapine; Ziprasidone; Aripiprazole |
|
AsenapineIloperidone; Cariprazine; Brexpipirazole; Summary; Conflict of Interest; Acknowledgments; References; Chapter 6: Depot Antipsychotics; Abstract; Introduction; History of Depot Antipsychotics; Advantages of Depot Antipsychotics; First-Generation Depot Antipsychotics; Fluphenazine Decanoate and Enanthate; Formulation and Pharmacokinetics; Dosing and Administration; Efficacy; Safety; Haloperidol Decanoate; Formulation and Pharmacokinetics; Dosing and Administration; Efficacy; Safety; Second-Generation Depot Antipsychotics; Risperidone Long Acting Injection |
|
Formulation and PharmacokineticsDosing and Administration; Efficacy; Safety; Paliperidone Palmitate; Formulation and Pharmacokinetics; Dosing and Administration; Efficacy; Safety; Olanzapine Pamoate; Formulation and Pharmacokinetics; Dosing and Administration; Efficacy; Safety; Conclusions; Disadvantages of Depot Antipsychotic Medication; Why use Depot Antipsychotics?; References; Part III: Atypical Antipsycholtic Use Adverse Effects; Chapter 7: Attitudes toward Psychiatric Drug Treatment in Schizophrenia: Socio Demographic and Illness-Related Factors; Abstract; Introduction; Method |
| Notes |
"Nova Biomedical" |
| Bibliography |
Includes bibliographical references and index |
| Notes |
Description based on print version record |
| Subject |
Antipsychotic drugs.
|
|
Antipsychotic drugs -- Side effects.
|
|
Medication abuse -- Prevention
|
|
Antipsychotic Agents
|
|
MEDICAL -- Pain Medicine.
|
|
MEDICAL -- Psychiatry -- Psychopharmacology.
|
|
Antipsychotic drugs
|
|
Antipsychotic drugs -- Side effects
|
|
Medication abuse -- Prevention
|
| Form |
Electronic book
|
| Author |
Schwartz, Thomas L., editor
|
|
Megna, James, editor
|
|
Topel, Michael E., editor
|
| LC no. |
2019720654 |
| ISBN |
9781622574599 |
|
1622574591 |
|
